Coronary Artery Calcium: Need for More Clarity in Guidelines

JACC: Cardiovascular Imaging

Volumn 10, Issue 2, 2017, Pages 154-156

  Blaha, Michael J ^a,b   Matsushita, Kunihiro ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

coronary artery calcification; guidelines; Heinz Nixdorf Recall study; primary prevention; statin indication

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CALCIUM;

ANKLE BRACHIAL INDEX; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CORONARY ARTERY CALCIUM SCORE; EDITORIAL; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; CALCINOSIS; CORONARY ARTERY DISEASE; RISK FACTOR;

CALCINOSIS; CALCIUM; CORONARY ARTERY DISEASE; HUMANS; RISK FACTORS;

EID: 84994524947     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2016.05.017     Document Type: Editorial

References (10)

1. 1 Martin, S.S., Sperling, L.S., Blaha, M.J., et al. Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines. J Am Coll Cardiol 65 (2015), 1361–1368.
2. 2 Goff, D.C. Jr., Lloyd-Jones, D.M., Bennett, G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2935–2959.
3. 3 Greenland, P., Alpert, J.S., Beller, G.A., et al. American College of Cardiology Foundation; American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 56 (2010), e50–e103.
4. 4 Yeboah, J., McClelland, R.L., Polonsky, T.S., et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308 (2012), 788–795.
5. 5 Yeboah, J., Young, R., McClelland, R.L., et al. Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol 67 (2016), 139–147.
6. 6 Blaha, M.J., Cainzos-Achirica, M., Greenland, P., et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 133 (2016), 849–858.
7. 7 Nasir, K., Bittencourt, M.S., Blaha, M.J., et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 66 (2015), 1657–1668.
8. 8 Pursnani, A., Massaro, J.M., D'Agostino, R.B. Sr., O'Donnell, C.J., Hoffmann, U., Guideline-based statin eligibility, coronary artery calcification, and cardiovascular events. JAMA 314 (2015), 134–141.
9. 9 Mahabadi, A.A., Möhlenkamp, S., Lehmann, N., et al. CAC score improves coronary and CV risk assessment above statin indication by ESC and AHA/ACC primary prevention guidelines. J Am Coll Cardiol Img 10 (2017), 143–153.
10. 10 Blaha, M.J., Blumenthal, R.S., Budoff, M.J., Nasir, K., Understanding the utility of zero coronary calcium as a prognostic test: a Bayesian approach. Circ Cardiovasc Qual Outcomes 4 (2011), 253–256.